Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Independent Director of Tribeca Strategic Acquisition Corp.
Andrew Oakley has served on the board of directors since May 2026. He is a seasoned finance executive who previously served as CFO and executive vice president of Autolus Therapeutics plc, and held similar CFO roles at Sosei Group Corporation in Japan, Vectura Group plc in the UK, and Actelion Pharmaceuticals Ltd in Switzerland. Since leaving Autolus in 2023, he has assisted privately held bio-pharmaceutical companies and served on boards of public and private companies in the U.S. and Europe. He is the Finance Chair for the Carter Burden Network and heads the Investment Committee for a non-profit endowment. Mr. Oakley holds a Bachelor of Economics degree from Macquarie University, an MBA from London Business School, and has been a Member of the Australian Institute of Chartered Accountants since 1987.
[Origin not recorded. Carried over from /people/oakley-andrew-john-9152, a second record for the same person.]
This record is keyed to SEC CIK 0002059152 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 4 institutional-holder rows on these vehicles, under 4 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.